Responsive e-Health Intervention for Perinatal Depression in Healthcare Settings
MMB
2 other identifiers
interventional
191
1 country
2
Brief Summary
Perinatal depression is experienced by at least 14-20% of pregnant and postpartum women, and is recognized as the most common complication of childbirth. In this project, the investigators plan to complete the process of making MomMoodBooster (MMB), a web-based cognitive-behavioral depression intervention, into a commercial ready product, MMB 2.0, that fits the workflow and staffing of healthcare organizations and is designed for both prenatal and postpartum women who are depressed. The investigators will also conduct a 2-arm randomized controlled trial to evaluate the efficacy of treatment as usual plus MMB 2.0 compared to treatment as usual in a large healthcare setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2018
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2018
CompletedFirst Submitted
Initial submission to the registry
June 17, 2019
CompletedFirst Posted
Study publicly available on registry
June 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedResults Posted
Study results publicly available
October 12, 2023
CompletedOctober 12, 2023
October 1, 2023
2.8 years
June 17, 2019
August 23, 2023
October 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Primary Health Questionnaire (PHQ-9)
The PHQ-9 measures self-reports of depressive symptoms within the prior 2 weeks and has been well-validated, shown high test-retest reliability, shown high internal consistency, and shown to be responsive to changes in treatment. Response options are on a 4-point scale (0 = not at all, 3 = nearly every day). The minimum overall score is 0 and the maximum overall score for the PHQ-9 is 27. Higher values represent more severe depression status.
Pretest (at enrollment) and posttest (3 months post enrollment)
Secondary Outcomes (5)
Change in General Anxiety Disorder (GAD)
Pretest (at enrollment) and posttest (3 months post enrollment)
Change in Stress
Pretest (at enrollment) and posttest (3 months post enrollment)
Change in Behavioral Activation for Depression Scale (BADS)
Pretest (at enrollment) and posttest (3 months post enrollment)
Change in Automatic Thoughts Questionnaire - Short Form (ATQ)
Pretest (at enrollment) and posttest (3 months post enrollment)
Change in Self-Efficacy
Pretest (at enrollment) and posttest (3 months post enrollment)
Study Arms (2)
Treatment As Usual + MMB 2.0
OTHERWomen assigned to use MMB 2.0, along with NorthShore HealthSystem's well established usual care, will be guided by the program to move sequentially through 6 sessions, one of which becomes available for use each week, while interacting with engaging activities within each session along with recommended practice activities to encourage transfer of learning and skills to everyday routines. Content is presented using text, interactions, animations, and videos. MMB includes daily tracking and charting of mood and pleasant activities as well as online access to a library, covering a range of issues of concern to pregnant women and new mothers. Integrated text messages offer both motivational messages and links to access specific portions of session content in the MMB 2.0 program. The study coordinator will also provide up to 3 supportive coaching calls to each woman in the MMB 2.0 condition. These calls complement and thus are adjunctive to the MMB 2.0 program.
Treatment As Usual Only
OTHERNorthShore HealthSystem's treatment as usual, or usual care, has been in place since 2003. Screen positive women randomized to this condition will receive social work assessment by phone, followed by community mental health referral as indicated. Referrals will vary by need and may include psychotherapy, support groups, or psychiatry. Referrals will include consideration of geographic proximity, insurance, and acuity. Consistent with routine practice, NorthShore staff will document time spent during evaluation and in making specific referrals.
Interventions
Women assigned to use MMB 2.0, along with NorthShore HealthSystem's well established usual care, will be guided by the program to move sequentially through 6 sessions, one of which becomes available for use each week, while interacting with engaging activities within each session along with recommended practice activities to encourage transfer of learning and skills to everyday routines. Content is presented using text, interactions, animations, and videos. MMB includes daily tracking and charting of mood and pleasant activities as well as online access to a library, covering a range of issues of concern to pregnant women and new mothers. Integrated text messages offer both motivational messages and links to access specific portions of session content in the MMB 2.0 program. The study coordinator will also provide up to 3 supportive coaching calls to each woman in the MMB 2.0 condition. These calls complement and thus are adjunctive to the MMB 2.0 program.
NorthShore HealthSystem's treatment as usual, or usual care, has been in place since 2003. Screen positive women randomized to this condition will receive social work assessment by phone, followed by community mental health referral as indicated. Referrals will vary by need and may include psychotherapy, support groups, or psychiatry. Referrals will include consideration of geographic proximity, insurance, and acuity. Consistent with routine practice, NorthShore staff will document time spent during evaluation and in making specific referrals.
Eligibility Criteria
You may qualify if:
- pregnant or postpartum
- have elevated Edinburgh Postnatal Depression Scale (EPDS) of ≥ 12
- access to broadband internet and a computer at home (desktop, laptop, tablet) or a smartphone (iOS or Android)
- English language proficiency sufficient to enable completion of the informed consent and to engage in all study activities that are delivered in English
You may not qualify if:
- Women assessed with active suicidal ideation will be excluded and provided with immediate psychiatric care consistent with NorthShore's established safety protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
NorthShore University HealthSystem
Chicago, Illinois, 60201, United States
Oregon Research Behavioral Intervention Strategies, Inc.
Springfield, Oregon, 97477, United States
Related Publications (1)
Danaher BG, Seeley JR, Silver RK, Tyler MS, Kim JJ, La Porte LM, Cleveland E, Smith DR, Milgrom J, Gau JM. Trial of a patient-directed eHealth program to ameliorate perinatal depression: the MomMoodBooster2 practical effectiveness study. Am J Obstet Gynecol. 2023 Apr;228(4):453.e1-453.e10. doi: 10.1016/j.ajog.2022.09.027. Epub 2022 Sep 26.
PMID: 36174746DERIVED
MeSH Terms
Interventions
Results Point of Contact
- Title
- David Smith
- Organization
- Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2019
First Posted
June 24, 2019
Study Start
August 24, 2018
Primary Completion
May 31, 2021
Study Completion
July 31, 2021
Last Updated
October 12, 2023
Results First Posted
October 12, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share